Wyoming’s U.S. Senator Mike Enzi is asking the Food and Drug Administration how it plans to implement the Emergency Use Authorization program for unapproved drugs, which Enzi said may play a crucial role in helping Americans return to some semblance of normal life during the COVID-19 pandemic. On May 1st, the FDA issued the authorization for Remdesivir – an antiviral medicine used to treat certain people in the hospital with COVID-19. There are more than 70 other clinical trials of potential COVID-19 therapies reportedly in progress. Enzi said the FDA can consider these for more authorizations, which would allow health providers to immediately administer the products while drug sponsors continue to pursue full FDA approval, which can take more than a decade.
- WYDOT Starts Collecting Fuel Tax on Public EV Charging: Ensuring Fair Road Funding - October 17, 2025
- Jim Darwiche Honored with 2025 Clarene Law Memorial Legacy Award - October 16, 2025
- Prepare for Jackson Hole Winter: Clear Streets, Sidewalks, and Join Fall Clean-Up by November 15th - October 16, 2025
